Arch Biopartners Appoints Dr. Patrick Vink as Chairman of the Board
Arch Biopartners; Patrick Vink; Chairman; Board of Directors; Claude Allary; kidney therapeutics
N.Y. Attorney General Sues Former Emergent BioSolutions CEO Robert Kramer for Insider Trading
insider trading; Emergent BioSolutions; Robert Kramer; New York AG; Letitia James; COVID-19 vaccine; AstraZeneca; stock sales
FW In Conversation: Mineralys CEO Jon Congleton on Reviving Hypertension Innovation and Lorundrostat’s Best-in-Class Potential
Mineralys Therapeutics; Jon Congleton; lorundrostat; aldosterone synthase inhibitor; hypertension treatment; FW In Conversation
Trump Unveils ‘The Great Healthcare Plan’ to Lower Drug Prices and Target Insurers
Trump; Great Healthcare Plan; drug pricing; insurance premiums; price transparency; healthcare reform
Teva Launches First Generic GLP-1 for Weight Loss Amid Ongoing Market Developments
generic GLP-1; Teva; liraglutide; Saxenda; FDA approval; weight loss drugs
J&J Reports Positive Phase 3 MajesTEC-9 Results for Tecvayli in Earlier Multiple Myeloma
Tecvayli; J&J; Phase 3; MajesTEC-9; multiple myeloma; PFS; OS
Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
Antengene; JPM Conference; ATG-022; ADCs; TCEs; AnTenGager; ATG-125; ATG-207
FDA Delays Reviews for Eli Lilly, Sanofi, and Others in New Priority Voucher Program Due to Safety and Efficacy Concerns
FDA delays; Eli Lilly; Sanofi; voucher program; orforglipron; Tzield; safety concerns; efficacy issues
Fosun Pharma’s Global Ambitions: Innovation-Driven Expansion in 2025
Fosun Pharma; global expansion; innovative drugs; 2025 results; licensing deals
Novo Nordisk Foundation Commits Over $850M to Danish Life Science Incubator BII Over Next Decade
Novo Nordisk Foundation; BII; life science incubator; $850M; biotech startups; Denmark